The Indian pharmaceutical market posted 11% growth in February 2026, driven by strong therapy performance, while Mounjaro remained India’s highest-selling drug by value for a fifth month
​The Indian pharmaceutical market posted 11% growth in February 2026, driven by strong therapy performance, while Mounjaro remained India’s highest-selling drug by value for a fifth month by Soban News (international And National News)
